Hyphema: Diagnosis and management

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


The management of traumatic hyphema has been controversial for many years. Treatments designed to prevent secondary hemorrhage have been proposed in the literature, then later abandoned when prospective studies failed to support them. In the last several years, published studies have demonstrated the efficacy of antifibrinolytic agents in the prevention of secondary hemorrhages. These studies have left unanswered some questions, however, such as whether antifibrinolytics are as effective in children as adults, in white patients as black, and in patients with normal hemoglobin as well as those with sickle cell hemoglobinopathies. The successful treatment of patients with hyphemas hinges on identification of risk factors, proper medical management and prompt surgical intervention when medical therapy fails.

Original languageEnglish (US)
Pages (from-to)S65-S71
StatePublished - Jan 1 1990


  • Aminocaproic acid
  • Hyphema
  • Management
  • Sickle cell trait

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Hyphema: Diagnosis and management'. Together they form a unique fingerprint.

Cite this